The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 19
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte BEI SHAN, R. MARC LEARNED, M. CATHERINE AMARAL,
STEVEN L. MCKNIGHT, FABIENNE CHARLES DE LA BROUSSE
and JIN-LONG CHEN
__________
Appeal No. 2000-04411
Application No. 08/866,942
__________
ON BRIEF
__________
Before WILLIAM F. SMITH, SCHEINER and GRIMES, Administrative Patent Judges.
SCHEINER, Administrative Patent Judge.
DECISION ON APPEAL
This is an appeal under 35 U.S.C. § 134 from the final rejection of claims 1-3 and
5-14, the only claims remaining in the application. Claims 1 and 5 are representative of
the subject matter on appeal:
1. An isolated genetic knock-in cell, wherein said cell is, or is a progeny of, a
genetic knock-in primary cell obtained from a transgenic mouse made by homologous
recombination of a targeted native allele with a transgene comprising a sequence
encoding a reporter flanked by flanking sequences which effect the homologous
recombination of said transgene with said native allele, wherein the expression of said
reporter is under the control of native gene expression regulatory sequences of said
native allele.
1 Application for patent filed May 31, 1997. According to appellants, this
application is a continuation-in-part of application no. 08/707,408, filed
September 4, 1996, now U.S. Patent no. 5,780,258.
Page: 1 2 3 4 5 6 7 Next
Last modified: November 3, 2007